Skip to main content
logo
Apellis Pharmaceuticals, Inc. (APLS)
May 14, 2026 - APLS was delisted (reason: acquired by BIIB)
41.03
-0.03 (-0.07%)
Inactive · Last trade price on May 13, 2026

Apellis Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
5,2533,1813,9737,1575,7284,611
Market Cap Growth
117.85%-19.93%-44.49%24.94%24.23%5.88%
Enterprise Value
5,3222,7263,6656,9105,2834,116
Last Close Price
41.0325.1231.9159.8651.7147.28

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
39.98125.60----
PS Ratio
4.753.175.0818.0575.9569.27
PB Ratio
12.658.5917.3836.7933.7223.21
P/FCF Ratio
140.2070.66----
P/OCF Ratio
139.0770.17----

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
4.822.724.6917.4270.0561.84
EV/EBITDA Ratio
31.9447.84----
EV/EBIT Ratio
32.2149.19----
EV/FCF Ratio
142.0660.57----

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.030.030.450.540.631.04
Debt / EBITDA Ratio
0.120.33----
Debt / FCF Ratio
0.530.42----
Net Debt / Equity Ratio
-0.93-1.21-1.32-1.24-2.58-2.47
Net Debt / EBITDA Ratio
-2.31-7.851.850.470.740.92
Net Debt / FCF Ratio
-10.29-9.933.410.400.850.87
Asset Turnover
1.021.020.930.510.090.07
Inventory Turnover
0.790.911.030.500.110.02
Quick Ratio
2.982.573.652.253.345.39
Current Ratio
3.633.144.253.104.296.25
Return on Equity (ROE)
68.94%7.48%-93.55%-290.14%-353.93%-370.20%
Return on Assets (ROA)
15.10%5.25%-19.83%-67.04%-72.50%-58.24%
Return on Invested Capital (ROIC)
37.00%15.11%-58.51%-298.26%-868.93%-4551.49%
Return on Capital Employed (ROCE)
21.31%7.64%-26.60%-91.22%-88.58%-67.79%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
2.54%0.80%----
FCF Yield
0.71%1.42%----
Buyback Yield / Dilution
-5.48%-4.80%-4.40%-11.84%-25.70%-12.32%
Total Shareholder Return
-5.48%-4.80%-4.40%-11.84%-25.70%-12.32%
SEC Filings: 10-K · 10-Q